P10 INC-A (PX) Stock Fundamental Analysis

NYSE:PX • US69376K1060

10.54 USD
+0.09 (+0.86%)
At close: Feb 10, 2026
10.54 USD
0 (0%)
After Hours: 2/10/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, PX scores 4 out of 10 in our fundamental rating. PX was compared to 238 industry peers in the Capital Markets industry. PX may be in some trouble as it scores bad on both profitability and health. PX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • PX had positive earnings in the past year.
  • PX had a positive operating cash flow in the past year.
  • Of the past 5 years PX 4 years were profitable.
  • Each year in the past 5 years PX had a positive operating cash flow.
PX Yearly Net Income VS EBIT VS OCF VS FCFPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

  • The Return On Assets of PX (1.64%) is worse than 62.60% of its industry peers.
  • With a Return On Equity value of 4.45%, PX is not doing good in the industry: 63.45% of the companies in the same industry are doing better.
  • PX has a better Return On Invested Capital (5.14%) than 67.23% of its industry peers.
  • PX had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 7.30%.
  • The 3 year average ROIC (3.89%) for PX is below the current ROIC(5.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.64%
ROE 4.45%
ROIC 5.14%
ROA(3y)1.61%
ROA(5y)2.03%
ROE(3y)3.66%
ROE(5y)10.38%
ROIC(3y)3.89%
ROIC(5y)3.42%
PX Yearly ROA, ROE, ROICPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.09%, PX is doing worse than 72.69% of the companies in the same industry.
  • PX's Profit Margin has declined in the last couple of years.
  • PX's Operating Margin of 20.75% is in line compared to the rest of the industry. PX outperforms 47.06% of its industry peers.
  • PX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.75%
PM (TTM) 5.09%
GM N/A
OM growth 3Y-8.6%
OM growth 5Y-6.43%
PM growth 3Y1.05%
PM growth 5Y-24.96%
GM growth 3YN/A
GM growth 5YN/A
PX Yearly Profit, Operating, Gross MarginsPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • PX has less shares outstanding than it did 1 year ago.
  • PX has more shares outstanding than it did 5 years ago.
  • PX has a worse debt/assets ratio than last year.
PX Yearly Shares OutstandingPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PX Yearly Total Debt VS Total AssetsPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.41, we must say that PX is in the distress zone and has some risk of bankruptcy.
  • PX's Altman-Z score of 1.41 is fine compared to the rest of the industry. PX outperforms 64.71% of its industry peers.
  • The Debt to FCF ratio of PX is 17.48, which is on the high side as it means it would take PX, 17.48 years of fcf income to pay off all of its debts.
  • PX's Debt to FCF ratio of 17.48 is in line compared to the rest of the industry. PX outperforms 58.40% of its industry peers.
  • PX has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
  • PX has a Debt to Equity ratio (1.14) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 17.49
Altman-Z 1.41
ROIC/WACCN/A
WACCN/A
PX Yearly LT Debt VS Equity VS FCFPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • PX has a Current Ratio of 0.98. This is a bad value and indicates that PX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of PX (0.98) is comparable to the rest of the industry.
  • PX has a Quick Ratio of 0.98. This is a bad value and indicates that PX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PX has a Quick ratio of 0.98. This is comparable to the rest of the industry: PX outperforms 42.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
PX Yearly Current Assets VS Current LiabilitesPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.43% over the past year.
  • PX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.62% yearly.
  • Looking at the last year, PX shows a quite strong growth in Revenue. The Revenue has grown by 9.77% in the last year.
  • PX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.86% yearly.
EPS 1Y (TTM)5.43%
EPS 3Y24.75%
EPS 5Y3.62%
EPS Q2Q%-7.69%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y25.35%
Revenue growth 5Y45.86%
Sales Q2Q%2.27%

3.2 Future

  • Based on estimates for the next years, PX will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.72% on average per year.
  • PX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.06% yearly.
EPS Next Y-7.96%
EPS Next 2Y5.44%
EPS Next 3Y8.72%
EPS Next 5YN/A
Revenue Next Year2.39%
Revenue Next 2Y10.02%
Revenue Next 3Y11.06%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PX Yearly Revenue VS EstimatesPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
PX Yearly EPS VS EstimatesPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.87 indicates a reasonable valuation of PX.
  • Based on the Price/Earnings ratio, PX is valued a bit cheaper than 63.45% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of PX to the average of the S&P500 Index (26.68), we can say PX is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.39, the valuation of PX can be described as reasonable.
  • 76.47% of the companies in the same industry are more expensive than PX, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. PX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.87
Fwd PE 9.39
PX Price Earnings VS Forward Price EarningsPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PX indicates a somewhat cheap valuation: PX is cheaper than 74.79% of the companies listed in the same industry.
  • PX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 51.54
EV/EBITDA 17.19
PX Per share dataPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3
EPS Next 2Y5.44%
EPS Next 3Y8.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • PX has a Yearly Dividend Yield of 1.39%.
  • Compared to an average industry Dividend Yield of 6.25, PX is paying slightly less dividend.
  • Compared to the average S&P500 Dividend Yield of 1.84, PX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

  • PX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of PX decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
PX Yearly Dividends per sharePX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 105.06% of the earnings are spent on dividend by PX. This is not a sustainable payout ratio.
DP105.06%
EPS Next 2Y5.44%
EPS Next 3Y8.72%
PX Yearly Income VS Free CF VS DividendPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
PX Dividend Payout.PX Dividend Payout, showing the Payout Ratio.PX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

P10 INC-A

NYSE:PX (2/10/2026, 8:04:00 PM)

After market: 10.54 0 (0%)

10.54

+0.09 (+0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners68.65%
Inst Owner Change-91.12%
Ins Owners20.61%
Ins Owner Change0.17%
Market Cap1.16B
Revenue(TTM)301.31M
Net Income(TTM)15.33M
Analysts81.54
Price Target16.96 (60.91%)
Short Float %5.78%
Short Ratio6.97
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP105.06%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.18%
Min EPS beat(2)0.22%
Max EPS beat(2)10.14%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-5.74%
Max EPS beat(4)11.29%
EPS beat(8)6
Avg EPS beat(8)8.11%
EPS beat(12)10
Avg EPS beat(12)7.97%
EPS beat(16)14
Avg EPS beat(16)7.09%
Revenue beat(2)0
Avg Revenue beat(2)-3%
Min Revenue beat(2)-5.07%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)11.75%
Revenue beat(8)4
Avg Revenue beat(8)1.36%
Revenue beat(12)7
Avg Revenue beat(12)2.14%
Revenue beat(16)10
Avg Revenue beat(16)1.82%
PT rev (1m)4.72%
PT rev (3m)10.83%
EPS NQ rev (1m)1.26%
EPS NQ rev (3m)-1.23%
EPS NY rev (1m)0.28%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.63%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)-1.32%
Valuation
Industry RankSector Rank
PE 10.87
Fwd PE 9.39
P/S 3.85
P/FCF 51.54
P/OCF 41.76
P/B 3.36
P/tB N/A
EV/EBITDA 17.19
EPS(TTM)0.97
EY9.2%
EPS(NY)1.12
Fwd EY10.65%
FCF(TTM)0.2
FCFY1.94%
OCF(TTM)0.25
OCFY2.39%
SpS2.74
BVpS3.13
TBVpS-2.98
PEG (NY)N/A
PEG (5Y)3
Graham Number8.27
Profitability
Industry RankSector Rank
ROA 1.64%
ROE 4.45%
ROCE 7.41%
ROIC 5.14%
ROICexc 5.39%
ROICexgc 32.93%
OM 20.75%
PM (TTM) 5.09%
GM N/A
FCFM 7.47%
ROA(3y)1.61%
ROA(5y)2.03%
ROE(3y)3.66%
ROE(5y)10.38%
ROIC(3y)3.89%
ROIC(5y)3.42%
ROICexc(3y)4.15%
ROICexc(5y)3.64%
ROICexgc(3y)42.32%
ROICexgc(5y)39%
ROCE(3y)5.62%
ROCE(5y)4.93%
ROICexgc growth 3Y14.25%
ROICexgc growth 5Y7.5%
ROICexc growth 3Y11.21%
ROICexc growth 5Y3.97%
OM growth 3Y-8.6%
OM growth 5Y-6.43%
PM growth 3Y1.05%
PM growth 5Y-24.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 17.49
Debt/EBITDA 4.47
Cap/Depr 20.64%
Cap/Sales 1.75%
Interest Coverage 2.41
Cash Conversion 31.54%
Profit Quality 146.76%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.41
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.31%
Cap/Depr(5y)5.71%
Cap/Sales(3y)0.97%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.43%
EPS 3Y24.75%
EPS 5Y3.62%
EPS Q2Q%-7.69%
EPS Next Y-7.96%
EPS Next 2Y5.44%
EPS Next 3Y8.72%
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y25.35%
Revenue growth 5Y45.86%
Sales Q2Q%2.27%
Revenue Next Year2.39%
Revenue Next 2Y10.02%
Revenue Next 3Y11.06%
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3Y14.58%
EBIT growth 5Y36.48%
EBIT Next Year-22.1%
EBIT Next 3Y-5.84%
EBIT Next 5YN/A
FCF growth 1Y-63.8%
FCF growth 3Y25.32%
FCF growth 5Y41.79%
OCF growth 1Y-56.3%
OCF growth 3Y27.23%
OCF growth 5Y43.11%

P10 INC-A / PX FAQ

What is the ChartMill fundamental rating of P10 INC-A (PX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PX.


What is the valuation status of P10 INC-A (PX) stock?

ChartMill assigns a valuation rating of 5 / 10 to P10 INC-A (PX). This can be considered as Fairly Valued.


How profitable is P10 INC-A (PX) stock?

P10 INC-A (PX) has a profitability rating of 3 / 10.


How financially healthy is P10 INC-A?

The financial health rating of P10 INC-A (PX) is 2 / 10.


Can you provide the expected EPS growth for PX stock?

The Earnings per Share (EPS) of P10 INC-A (PX) is expected to decline by -7.96% in the next year.